ANI Pharmaceuticals
ANIP
ANIP
184 hedge funds and large institutions have $480M invested in ANI Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 71 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 175 → 184 (+9)
4.15% more ownership
Funds ownership: 56.85% → 60.99% (+4.1%)
Holders
184
Holding in Top 10
2
Calls
$8.13M
Puts
$3.26M
Top Buyers
| 1 | +$6.33M | |
| 2 | +$5.28M | |
| 3 | +$3.14M | |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$2.79M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$2.43M |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$2.6M | |
| 3 | -$2.49M | |
| 4 |
JG
Jefferies Group
New York
|
-$1.7M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.21M |